BIOMAT Database Logo BIOMAT Database Logo

High-throughput synthesis of HepDirect prodrugs of nucleoside monophosphates. 2008

Brett C Bookser, and Nicholas B Raffaele
Metabasis Therapeutics, Inc., 11119 North Torrey Pines Road, La Jolla, California 92037, USA. bookser@mbasis.com

A high-throughput phosphoramidite method for HepDirect prodrug synthesis was optimized on seven representative nucleosides, adenosine, inosine, guanosine, uridine, cytidine, AICA-riboside, and thymidine, each on a 5 mg scale. The variables optimized included (1) reaction time, (2) reaction temperature, (3) activating agent, (4) solvent, (5) purification method, and (6) stoichiometry. Preparative HPLC with mass-based fraction collection and yield determination from an ELSD standard curve enabled high-throughput. The optimized conditions for the representative nucleosides required 6 mol equiv of phosphoramidite to nucleoside and resulted in an average HPLC determined yield of 31 +/- 14% and HPLC purity of 93 +/- 3%.

UI MeSH Term Description Entries
D009705 Nucleosides Purine or pyrimidine bases attached to a ribose or deoxyribose. (From King & Stansfield, A Dictionary of Genetics, 4th ed) Nucleoside,Nucleoside Analog,Nucleoside Analogs,Analog, Nucleoside,Analogs, Nucleoside
D010710 Phosphates Inorganic salts of phosphoric acid. Inorganic Phosphate,Phosphates, Inorganic,Inorganic Phosphates,Orthophosphate,Phosphate,Phosphate, Inorganic
D011355 Prodrugs A compound that, on administration, must undergo chemical conversion by metabolic processes before becoming the pharmacologically active drug for which it is a prodrug. Drug Precursor,Drug Precursors,Pro-Drug,Prodrug,Pro-Drugs,Precursor, Drug,Precursors, Drug,Pro Drug,Pro Drugs
D015394 Molecular Structure The location of the atoms, groups or ions relative to one another in a molecule, as well as the number, type and location of covalent bonds. Structure, Molecular,Molecular Structures,Structures, Molecular

Related Publications

Brett C Bookser, and Nicholas B Raffaele
Liver-targeted drug delivery using HepDirect prodrugs.
February 2005, The Journal of pharmacology and experimental therapeutics,
Brett C Bookser, and Nicholas B Raffaele
Synthesis of nucleoside phosphate and phosphonate prodrugs.
September 2014, Chemical reviews,
Brett C Bookser, and Nicholas B Raffaele
Nucleoside-5'-monophosphates as prodrugs of adenosine A2A receptor agonists activated by ecto-5'-nucleotidase.
December 2009, Journal of medicinal chemistry,
Brett C Bookser, and Nicholas B Raffaele
An enzymatic alternative for the synthesis of nucleoside 5'-monophosphates.
April 2018, Enzyme and microbial technology,
Brett C Bookser, and Nicholas B Raffaele
Synthesis of Nucleoside-5'-O-Tetraphosphates from Activated Trimetaphosphate and Nucleoside-5'-O-Monophosphates.
December 2018, Current protocols in nucleic acid chemistry,
Brett C Bookser, and Nicholas B Raffaele
Synthesis of 5'-amino-5'-phosphonate analogues of pyrimidine nucleoside monophosphates.
August 2003, The Journal of organic chemistry,
Brett C Bookser, and Nicholas B Raffaele
Polynucleotides. 23. A synthesis of ribodinucleoside monophosphates using nucleoside 5'-phosphates.
February 1974, Nucleic acids research,
Brett C Bookser, and Nicholas B Raffaele
HepDirect prodrugs for targeting nucleotide-based antiviral drugs to the liver.
February 2006, Current opinion in investigational drugs (London, England : 2000),
Brett C Bookser, and Nicholas B Raffaele
Biocatalytic approaches applied to the synthesis of nucleoside prodrugs.
January 2015, Biotechnology advances,
Brett C Bookser, and Nicholas B Raffaele
Synthesis and biological studies of novel nucleoside phosphoramidate prodrugs.
December 2001, Journal of medicinal chemistry,
Copied contents to your clipboard!